| Who needs this | Food, beverage, dietary supplement, cosmetic, OTC drug, and medical device companies selling in the U.S. |
|---|---|
| What’s reviewed | Product labels, packaging, inserts, websites, ads, social media, influencer content, sales scripts |
| Legal basis | FD&C Act misbranding provisions (21 U.S.C. §§ 343, 352, 362) and labeling regulations at 21 CFR Parts 101, 201, 701, and 801 |
| What’s at stake | FDA warning letters, import alerts/detention, product seizure, injunctions — and in serious cases, criminal liability |
| Who should do it | An attorney, not just a labeling consultant — see why that matters below |
What Is an FDA Label Review?
The FDA generally decides how strictly a product is regulated based on its intended use — and the single biggest signal of intended use is what you say about the product. Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), “labeling” isn’t just the sticker on the bottle. It legally includes any written, printed, or graphic material accompanying the product — which the FDA and courts have read to cover your website, social media posts, sales sheets, and even influencer content, not just the physical label.
That means a single unsupported claim in an Instagram caption can push a cosmetic into being regulated as an unapproved drug, or turn a dietary supplement into a misbranded product — regardless of what the physical label says. An FDA label review checks every piece of consumer-facing content against the relevant statute and regulations before it ships, and flags exactly which statements are compliant, which are risky, and which need to come out entirely.
Why FDA Label Reviews Matter
Selling a product with a noncompliant label or marketing claim is not a paperwork issue — it’s a federal violation. Under the FD&C Act, a product is misbranded if its labeling is “false or misleading in any particular” (21 U.S.C. § 321(n)), and separate misbranding provisions apply to food (§ 343), drugs and devices (§ 352), and cosmetics (§ 362). The FDA doesn’t need to prove anyone was harmed — a misleading claim alone is enough to trigger enforcement.
In practice, that enforcement looks like:
- Warning letters — public, and typically first on Google when someone searches your brand name
- Import detention — shipments held or refused entry at the border
- Seizure and injunction — the FDA can ask a federal court to pull products from shelves or stop a company from operating
- Reclassification — a cosmetic or supplement making the wrong kind of claim can be regulated as an unapproved new drug, which carries far stricter requirements
- Civil and, in egregious cases, criminal liability for the company and its officers
A label review is materially cheaper than any one of these outcomes, and unlike most compliance costs, it’s a one-time expense per label or campaign rather than an ongoing one.
Not sure if your current label or marketing would survive an FDA review? Get an attorney's eyes on it before you find out the hard way.
Schedule a ConsultationWhat We Review, By Product Type
| Product category | Governing framework | What we check for |
|---|---|---|
| Food & beverage | FD&C Act § 403; 21 CFR Part 101; FALCPA/FASTER Act | Ingredient statement and order, all 9 major allergens, Nutrition Facts formatting, net quantity, “natural”/”organic” claims, health and nutrient content claims |
| Dietary supplements | DSHEA (1994); 21 CFR Part 101, Subpart D | Structure/function claim wording and required disclaimer, disease-claim creep, Supplement Facts panel, 30-day FDA notification requirements |
| Cosmetics | FD&C Act § 602; 21 CFR Part 701; MoCRA (2022) | Drug-claim creep (e.g., “reduces wrinkles” vs. “anti-aging”), responsible-person identification, fragrance allergen disclosure, facility registration and product listing under MoCRA |
| OTC drugs | FD&C Act § 502; 21 CFR Part 201; OTC monographs | Monograph compliance, Drug Facts panel, indications and warnings language |
| Medical devices | FD&C Act § 502; 21 CFR Part 801 | Intended use statements, 510(k)/general wellness classification issues, labeling claims that could trigger a higher device class |
What’s Included in an FDA Label and Marketing Review
- Reviewing your labels and marketing materials — packaging, inserts, website copy, ads, social posts, and sales scripts — to flag impermissible or unsubstantiated claims
- Explaining why a claim is a problem, tied to the specific statute or regulation, so your team understands the line and not just the redline
- Suggesting compliant alternative language that keeps your marketing message intact while reducing enforcement risk
- A final compliance pass on the revised content before it goes live
- Ongoing review as you launch new SKUs, campaigns, or claims, so compliance isn’t a one-time event
The Claims We Review
Where a claim falls on this spectrum determines how strictly your product gets regulated — this is the single most common way companies accidentally reclassify their own product.
Structure/Function Claims
Describe how an ingredient affects the normal structure or function of the body — e.g., “calcium builds strong bones” or “supports joint health.” Dietary supplements making these claims must carry the disclaimer that “This statement has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease,” and the manufacturer must notify FDA within 30 days of marketing. (See our dedicated page on structure/function claims.)
Health Claims
Claim a relationship between a substance and reduced risk of a disease or health condition (e.g., “calcium may reduce the risk of osteoporosis”). Unlike structure/function claims, health claims generally require FDA authorization or qualification before use. (See health claims.)
Nutrient Content Claims
Characterize the level of a nutrient in a product — “low fat,” “high fiber,” “excellent source of vitamin C” — and must meet specific FDA definitions to use those exact terms. (See nutrient content claims.)
Disease Claims — the Line You Can’t Cross
Assert that a product treats, cures, mitigates, or prevents a specific disease (e.g., “treats arthritis,” “cures acne”). Only an approved drug can legally make a disease claim — a cosmetic, food, or dietary supplement that does risks being regulated as an unapproved new drug, one of the fastest paths to a warning letter. (See disease claims.)
Our FDA Label Review Process
- Submit your materials — labels, packaging proofs, website copy, and any ad or social content you want reviewed
- Attorney review against the specific statute and regulations that apply to your product category
- Written report flagging each claim as compliant, at-risk, or noncompliant, with the reasoning and citation behind each flag
- Revision support — we suggest compliant alternative language rather than just telling you what to remove
- Final sign-off on the revised version before it ships or goes live
Add your firm’s typical turnaround time and pricing structure here once confirmed — e.g., “Most single-label reviews are completed within X business days.”
Why Work With an FDA Regulatory Attorney, Not Just a Consultant
FDA labeling consultants can catch formatting errors — a missing allergen declaration, an incorrect Nutrition Facts format. What they generally can’t do:
- Attorney-client privilege. Communications with your attorney about a risky claim are privileged; communications with a non-attorney consultant generally are not, and can be discoverable if the FDA or a plaintiff’s lawyer comes looking later.
- Enforcement-tested judgment. An attorney who has actually handled warning letter responses and FDA enforcement actions reads a claim differently than someone who has only reviewed labels for formatting compliance — because they’ve seen which claims actually trigger action.
- Representation if it escalates. If a label issue turns into a warning letter, an import detention, or litigation, the same attorney who reviewed your label can represent you — a labeling consultant cannot.
Frequently Asked Questions
- What is an FDA label review?
- An FDA label review is a legal review of a product’s label, packaging, and marketing materials against FDA labeling regulations and the misbranding provisions of the FD&C Act, performed before the product ships or the marketing runs.
- Does the FDA pre-approve product labels or marketing claims?
- No, in most cases. The FDA does not pre-approve most food, cosmetic, or dietary supplement labels or marketing claims before they go to market. Compliance is the company’s responsibility, and the FDA enforces after the fact — through warning letters, import detention, or seizure — which is exactly why a review beforehand matters.
- What happens if my product label or marketing is found noncompliant?
- Outcomes range from a warning letter (public and often the first Google result for your brand) to import detention at the border, product seizure, an injunction, or reclassification of your product as an unapproved drug. Repeated or willful violations can carry civil and criminal exposure.
- What’s the difference between a structure/function claim, a health claim, a nutrient content claim, and a disease claim?
- Structure/function claims describe a normal effect on the body (e.g., “supports immune health”) and require a specific disclaimer. Health claims describe a reduced disease risk and generally require FDA authorization. Nutrient content claims describe the amount of a nutrient in a product (“low sodium”). Disease claims say a product treats, cures, or prevents a disease — and only an approved drug can legally make one.
- What products need an FDA label review?
- Food and beverage products, dietary supplements, cosmetics, OTC drugs, and medical devices sold in the U.S. all fall under FDA labeling jurisdiction, each governed by different statutory and regulatory requirements.
- How did MoCRA change cosmetic label review?
- The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) is the biggest expansion of FDA’s cosmetics authority since 1938. It added mandatory facility registration and product listing, adverse event reporting, safety substantiation recordkeeping, and gave FDA mandatory recall authority for cosmetics — on top of the existing labeling and drug-claim requirements.
- Why hire an attorney instead of a labeling consultant?
- An attorney’s review is protected by attorney-client privilege, draws on direct experience with FDA enforcement actions rather than formatting checklists alone, and means the same person who reviewed your label can represent you if the FDA follows up.
- How long does an FDA label review take, and what does it cost?
- Firm to confirm exact turnaround and pricing — pages with concrete numbers convert and get cited by AI answer engines more often than pages that only say “contact us for a quote.”
Not sure if your current label or marketing would survive an FDA review? Get an attorney's eyes on it before you find out the hard way.
Toll-free: (866) 785-0873
Direct: (305) 507-9843
Email: contact@giannamore-law.com
Schedule a ConsultationThe information on this page is for general informational purposes only, may not reflect the most current legal or regulatory developments, and does not constitute legal advice or create an attorney-client relationship.